YAHOO FINANCE CHARTBOOK 44 charts that explain markets and the economy right now Akero Therapeutics Stock Nearly Doubles — Pulling 89bio Higher — On Positive MASH Study Akero Therapeutics Stock Nearly Doubles — Pulling 89bio Higher — On Positive MASH Study · Investor's Business Daily ALLISON GATLIN Mon, Jan 27, 2025, 2:24 PM 2 min read In This Article: AKRO ETNB Akero Therapeutics nearly doubled Monday — and pulled 89bio shares higher — after the company's treatment for MASH obliterated expectations. Continue Reading View Comments Terms and Privacy Policy Your Privacy Choices Utah Privacy Notice Recommended Stories